Nasdaq Mirm News Today

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report)’s stock price reached a new 52-week low during mid-day trading on Thursday . The company traded as low as $23.14 and last traded at $23.47, with a volume of 36618 shares changing hands. The stock had previously closed at $24.02. Analyst Ratings Changes MIRM has been the […]

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) – Equities researchers at HC Wainwright dropped their FY2023 EPS estimates for Mirum Pharmaceuticals in a research note issued on Tuesday, February 27th. HC Wainwright analyst E. Arce now forecasts that the company will earn ($2.44) per share for the year, down from their previous estimate of ($2.13). […]

Healthcare of Ontario Pension Plan Trust Fund bought a new stake in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 100,000 shares of the company’s stock, valued at approximately $3,160,000. Healthcare of Ontario Pension […]

Jump Financial LLC increased its position in shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) by 607.0% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 87,384 shares of the company’s stock after purchasing an additional 75,024 shares during the quarter. Jump […]

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) – Stock analysts at HC Wainwright lifted their FY2025 earnings per share (EPS) estimates for shares of Mirum Pharmaceuticals in a research note issued on Tuesday, January 9th. HC Wainwright analyst E. Arce now expects that the company will post earnings per share of $3.37 for the year, […]

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report) insider Lara Longpre sold 1,019 shares of Mirum Pharmaceuticals stock in a transaction dated Monday, January 8th. The shares were sold at an average price of $28.04, for a total transaction of $28,572.76. Following the transaction, the insider now owns 105,254 shares of the company’s stock, valued […]

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report) SVP Jolanda Howe sold 528 shares of the firm’s stock in a transaction that occurred on Monday, January 8th. The stock was sold at an average price of $28.04, for a total transaction of $14,805.12. Following the completion of the transaction, the senior vice president now directly […]

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report) insider Lara Longpre sold 1,019 shares of the business’s stock in a transaction on Monday, January 8th. The shares were sold at an average price of $28.04, for a total transaction of $28,572.76. Following the sale, the insider now directly owns 105,254 shares of the company’s stock, […]

Mirum Pharmaceuticals (NASDAQ:MIRM – Get Free Report)‘s stock had its “market outperform” rating reaffirmed by investment analysts at JMP Securities in a research report issued to clients and investors on Thursday, Benzinga reports. They currently have a $64.00 price objective on the stock. JMP Securities’ price objective points to a potential upside of 142.15% from […]

Mirum Pharmaceuticals (NASDAQ:MIRM – Get Free Report)‘s stock had its “market outperform” rating reiterated by research analysts at JMP Securities in a research report issued to clients and investors on Thursday, Benzinga reports. They presently have a $64.00 price objective on the stock. JMP Securities’ price objective would indicate a potential upside of 142.15% from […]